University of Southern California: Carcinoma, Renal Cell trials
The registry lists 10 Carcinoma, Renal Cell studies with University of Southern California as lead sponsor. 0 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 1 3Phase 2 2No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
- Social Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWithdrawnNCT03408561Not applicable
- Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney CancerActive, not recruitingNCT03092856Phase 2
- sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney CancerTerminatedNCT02767921Phase 1
- Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney CancerActive, not recruitingNCT02664883
- Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing SurgeryWithdrawnNCT02370342Not applicable
- Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney CancerCompletedNCT02370290
- Clamped or Unclamped Surgery in Treating Patients With Kidney CancerTerminatedNCT01547676Not applicable
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)Status unknownNCT00184015Phase 1/2